Class information for:
Level 1: MYELIN OLIGODENDROCYTE GLYCOPROTEIN//MULTIPLE SCLEROSIS//NEUROIMMUNOL

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
10963 1020 46.3 89%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
207 3       MULTIPLE SCLEROSIS//MYASTHENIA GRAVIS//MULTIPLE SCLEROSIS JOURNAL 52279
58 2             MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA 29459
10963 1                   MYELIN OLIGODENDROCYTE GLYCOPROTEIN//MULTIPLE SCLEROSIS//NEUROIMMUNOL 1020

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN authKW 552565 6% 31% 60
2 MULTIPLE SCLEROSIS authKW 263059 42% 2% 426
3 NEUROIMMUNOL address 169447 11% 5% 110
4 PEPTIDE PROT CHEM BIOL address 151752 2% 30% 17
5 INTRATHECAL IGG authKW 106908 0% 71% 5
6 CLINICALLY ISOLATED SYNDROME authKW 99329 3% 10% 33
7 AXONAL DAMAGE authKW 92566 2% 13% 23
8 IGM OLIGOCLONAL BANDS authKW 89805 0% 100% 3
9 NEUROIMMUNOL UNIT address 83161 6% 5% 57
10 NEUROFILAMENT HEAVY CHAIN authKW 77192 1% 37% 7

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Clinical Neurology 7348 37% 0% 380
2 Neurosciences 5843 44% 0% 452
3 Immunology 4605 33% 0% 335
4 Biochemical Research Methods 144 5% 0% 50
5 Medicine, Research & Experimental 124 5% 0% 54
6 Pathology 102 4% 0% 36
7 Biochemistry & Molecular Biology 23 9% 0% 92
8 Psychiatry 13 2% 0% 25
9 Medical Laboratory Technology 7 1% 0% 7
10 Pharmacology & Pharmacy 5 4% 0% 43

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 NEUROIMMUNOL 169447 11% 5% 110
2 PEPTIDE PROT CHEM BIOL 151752 2% 30% 17
3 NEUROIMMUNOL UNIT 83161 6% 5% 57
4 CLIN NEUROIMMUNOL 71265 3% 8% 29
5 ORGAN CHEM UGO IFF 69601 1% 23% 10
6 NUBIN 67352 0% 75% 3
7 MUNICH GERMAN COMPETENCE NETWORK MULTIPLE SCLEROS 59870 0% 100% 2
8 PEPT UCP PLATFORM CHEM BIOL EA4505 59870 0% 100% 2
9 SOSCO PEPT 59870 0% 100% 2
10 TRAUMA NEUROSCI 59870 0% 100% 2

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 JOURNAL OF NEUROIMMUNOLOGY 59911 11% 2% 116
2 MULTIPLE SCLEROSIS JOURNAL 49118 6% 3% 62
3 MULTIPLE SCLEROSIS 6470 1% 2% 11
4 ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 6205 1% 3% 8
5 ANNALS OF NEUROLOGY 4941 4% 0% 36
6 THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 4882 0% 3% 5
7 MULTIPLE SCLEROSIS AND RELATED DISORDERS 2901 1% 2% 6
8 JOURNAL OF NEUROIMMUNE PHARMACOLOGY 2364 1% 1% 7
9 JOURNAL OF NEUROINFLAMMATION 1771 1% 1% 10
10 AUTOIMMUNITY REVIEWS 1761 1% 1% 10

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN 552565 6% 31% 60 Search MYELIN+OLIGODENDROCYTE+GLYCOPROTEIN Search MYELIN+OLIGODENDROCYTE+GLYCOPROTEIN
2 MULTIPLE SCLEROSIS 263059 42% 2% 426 Search MULTIPLE+SCLEROSIS Search MULTIPLE+SCLEROSIS
3 INTRATHECAL IGG 106908 0% 71% 5 Search INTRATHECAL+IGG Search INTRATHECAL+IGG
4 CLINICALLY ISOLATED SYNDROME 99329 3% 10% 33 Search CLINICALLY+ISOLATED+SYNDROME Search CLINICALLY+ISOLATED+SYNDROME
5 AXONAL DAMAGE 92566 2% 13% 23 Search AXONAL+DAMAGE Search AXONAL+DAMAGE
6 IGM OLIGOCLONAL BANDS 89805 0% 100% 3 Search IGM+OLIGOCLONAL+BANDS Search IGM+OLIGOCLONAL+BANDS
7 NEUROFILAMENT HEAVY CHAIN 77192 1% 37% 7 Search NEUROFILAMENT+HEAVY+CHAIN Search NEUROFILAMENT+HEAVY+CHAIN
8 OLIGOCLONAL BANDS 76831 2% 11% 23 Search OLIGOCLONAL+BANDS Search OLIGOCLONAL+BANDS
9 MOG 68703 1% 15% 15 Search MOG Search MOG
10 B CELLS 62078 10% 2% 100 Search B+CELLS Search B+CELLS

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 MAYER, MC , MEINL, E , (2012) GLYCOPROTEINS AS TARGETS OF AUTOANTIBODIES IN CNS INFLAMMATION: MOG AND MORE.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 5. ISSUE 3. P. 147-159 54 78% 31
2 LEE, DH , LINKER, RA , (2012) THE ROLE OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN IN AUTOIMMUNE DEMYELINATION: A TARGET FOR MULTIPLE SCLEROSIS THERAPY?.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 16. ISSUE 5. P. 451 -462 71 66% 4
3 FRAUSSEN, J , CLAES, N , DE BOCK, L , SOMERS, V , (2014) TARGETS OF THE HUMORAL AUTOIMMUNE RESPONSE IN MULTIPLE SCLEROSIS.AUTOIMMUNITY REVIEWS. VOL. 13. ISSUE 11. P. 1126 -1137 79 47% 16
4 WEBER, MS , HEMMER, B , CEPOK, S , (2011) THE ROLE OF ANTIBODIES IN MULTIPLE SCLEROSIS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1812. ISSUE 2. P. 239-245 59 63% 41
5 RAMANATHAN, S , DALE, RC , BRILOT, F , (2016) ANTI-MOG ANTIBODY: THE HISTORY, CLINICAL PHENOTYPE, AND PATHOGENICITY OF A SERUM BIOMARKER FOR DEMYELINATION.AUTOIMMUNITY REVIEWS. VOL. 15. ISSUE 4. P. 307 -324 60 51% 3
6 REINDL, M , KHALIL, M , BERGER, T , (2006) ANTIBODIES AS BIOLOGICAL MARKERS FOR PATHOPHYSIOLOGICAL PROCESSES IN MS.JOURNAL OF NEUROIMMUNOLOGY. VOL. 180. ISSUE 1-2. P. 50-62 64 57% 44
7 MAYER, MC , HOHLFELD, R , MEINL, E , (2012) VIABILITY OF AUTOANTIBODY-TARGETS: HOW TO TACKLE PATHOGENETIC HETEROGENEITY AS AN OBSTACLE FOR TREATMENT OF MULTIPLE SCLEROSIS.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 319. ISSUE 1-2. P. 2-7 40 77% 4
8 PIKOR, N , GOMMERMAN, JL , (2012) B CELLS IN MS: WHY, WHERE AND HOW?.MULTIPLE SCLEROSIS AND RELATED DISORDERS. VOL. 1. ISSUE 3. P. 123-130 50 60% 2
9 HOHLFELD, R , DORNMAIR, K , MEINL, E , WEKERLE, H , (2016) THE SEARCH FOR THE TARGET ANTIGENS OF MULTIPLE SCLEROSIS, PART 2: CD8+T CELLS, B CELLS, AND ANTIBODIES IN THE FOCUS OF REVERSE-TRANSLATIONAL RESEARCH.LANCET NEUROLOGY. VOL. 15. ISSUE 3. P. 317 -331 53 34% 6
10 FIALOVA, L , BARTOS, A , SVARCOVA, J , ZIMOVA, D , KOTOUCOVA, J , MALBOHAN, I , (2013) SERUM AND CEREBROSPINAL FLUID LIGHT NEUROFILAMENTS AND ANTIBODIES AGAINST THEM IN CLINICALLY ISOLATED SYNDROME AND MULTIPLE SCLEROSIS.JOURNAL OF NEUROIMMUNOLOGY. VOL. 262. ISSUE 1-2. P. 113-120 35 70% 12

Classes with closest relation at Level 1



Rank Class id link
1 14096 OLIGOCLONAL BANDS//INTRATHECAL SYNTHESIS//IGG INDEX
2 1541 EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS//MYELIN BASIC PROTEIN
3 6319 NEUROMYELITIS OPTICA//NEUROMYELITIS OPTICA SPECTRUM DISORDER//DEVICS DISEASE
4 702 MULTIPLE SCLEROSIS//NEUROIMAGING UNIT//NMR UNIT
5 22707 MULTIPLE SCLEROSIS//SOLUBLE VASCULAR CELL ADHESION MOLECULES//GRP MULTIPLE SCLEROSIS NEUROIMMUNOL
6 22413 ALEMTUZUMAB//DACLIZUMAB//MS CLIN CENT TEXAS
7 12463 REGULATORY B CELLS//B10 CELLS//BREGS
8 8216 JOURNAL OF NEUROIMMUNOLOGY//ANTI MBP//ACTA NEUROLOGICA SCANDINAVICA
9 30080 NEUROIMMUNOL UNIT DIBIT//BIOCHEM PHARMACOL EXPT PATHOL//DIPARTIMENTO MED SISTEMI
10 8190 MULTIPLE SCLEROSIS//FAMILIAL MULTIPLE SCLEROSIS//PROGRAM NEUROPSYCHIAT GENOM

Go to start page